Product Images Gabapentin

This text appears to be a formula or equation involving weight, serum creatinine levels, and CLCr (potentially an abbreviation for creatinine clearance). Without additional context or information, it is difficult to provide a more specific description or interpretation.*

This text appears to be a chart displaying the Mean Pain Score and dosing information for a medication. The chart shows a 4-week Dose Titration Period followed by a 4-week Fixed Dose Period with two treatment options: Placebo and Gabapentin at 3600 mg/day. The baseline pain score is not provided.*

This is a graph displaying the results of a study that had a 3-week dose titration period followed by a 4-week fixed dose period. Subjects were either given a placebo, Gabapentin at 1800mg/day, or Gabapentin at 2400mg/day. The graph shows the mean pain score over time, with the baseline score being 4 and decreasing to 1 by week 7.*

The given text seems to display a chart or list that includes percentage values ranging from 0 to 100 in increments of 10, with annotations denoting statistical significance (*p<0001). There is also mention of a study 2 and financial figures labeled in GBP (Great British Pounds). It is unclear though what exactly the chart or list is representing, making any further description not-available.*

This is a description of Gabapentin tablets, USP 600 mg, ND 100 Tablets (10x10), distributed by McKesson Corporation. It contains important information such as the GTIN, lot number, expiration date, and usual dosage. It is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India. The tablets should be stored at room temperature and kept out of reach of children. This drug should be taken based on a doctor's prescription.*